Literature DB >> 10820206

Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-d-aspartate-induced necrosis in mouse cortical neurons.

H W Ko1, K S Han, E Y Kim, B R Ryu, W J Yoon, Y K Jung, S U Kim, B J Gwag.   

Abstract

We examined the possibility that p38 mitogen-activated protein kinase and caspase-3 would be activated for execution of apoptosis and excitotoxicity, the two major types of neuronal death underlying hypoxicischemic and neurodegenerative diseases. Mouse cortical cell cultures underwent widespread neuronal apoptosis 24 h following exposure to 10-30 nM calyculin A, a selective inhibitor of Ser/Thr phosphatase I and IIA. Activity of p38 was increased 2-4 h following exposure to 30 nM calyculin A. Addition of 3-10 microM PD169316, a selective p38 inhibitor, partially attenuated calyculin A neurotoxicity. Activity of caspase-3-like proteases was increased in cortical cell cultures exposed to 30 nM calyculin A for 8-16 h as shown by cleavage of DEVD-p-nitroanilide and phosphorylated tau. Proteolysis of tau was completely blocked by addition of 100 microM N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (z-VAD-fmk), a broad-spectrum inhibitor of caspases, but incompletely by 10 microM PD169316. Calyculin A neurotoxicity was partially sensitive to 100 microM z-VAD-fmk. Cotreatment with 10 microM PD169316 and 100 microM z-VAD-fmk showed additive neuroprotection against calyculin A. Neither PD169316 nor z-VAD-fmk showed a beneficial effect against excitotoxic neuronal necrosis induced by exposure to 20 microM NMDA. Thus, caspase-3-like proteases and p38 likely contribute to calyculin A-induced neuronal apoptosis but not NMDA-induced neuronal necrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820206     DOI: 10.1046/j.1471-4159.2000.0742455.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

2.  Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.

Authors:  Mohammed M H Al-Gayyar; Mohammed A Abdelsaid; Suraporn Matragoon; Bindu A Pillai; Azza B El-Remessy
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

3.  The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival.

Authors:  Zhao Zhong Chong; Shi-Hua Lin; Jing-Qiong Kang; Kenneth Maiese
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

4.  Caspase 3 activity is required for skeletal muscle differentiation.

Authors:  Pasan Fernando; John F Kelly; Kim Balazsi; Ruth S Slack; Lynn A Megeney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

5.  RHOA signaling defects result in impaired axon guidance in iPSC-derived neurons from patients with tuberous sclerosis complex.

Authors:  Timothy S Catlett; Massimo M Onesto; Alec J McCann; Sarah K Rempel; Jennifer Glass; David N Franz; Timothy M Gómez
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

6.  Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.

Authors:  Antonella Muscella; Carla Vetrugno; Luca Giulio Cossa; Giovanna Antonaci; Amilcare Barca; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

7.  In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.

Authors:  Antonella Muscella; Carla Vetrugno; Luca Giulio Cossa; Giovanna Antonaci; Francesco De Nuccio; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.